Literature DB >> 31938202

LncRNA H19 promotes proliferation and invasion in A375 human melanoma cell line.

Xiaoling Zhu1, Wei Li2, Qinggang Meng2.   

Abstract

OBJECTIVE: To determine the effects of H19 gene on the proliferation and invasion of A375 human melanoma cells.
METHODS: A375 cells were infected with a lentiviral vector overexpressing H19 or transfected with H19 RNA interference constructs. The proliferation and invasion of A375/H19+ cells were measured by MTT cell viability and transwell assays, respectively. The mRNA and protein expression levels of matrix metalloproteinase 2 (MMP2) and MMP9 were measured by quantitative PCR (qPCR) and Western blotting, respectively, and the protein expression of Akt, phosphorylated Akt (p-Akt), Slug and E-cadherin were examined by Western blot analysis.
RESULTS: The optical density value of A375/H19+ cells increased after incubation with MTT reagent for 12 h (P < 0.05), and the transwell assay showed that the average penetration rate of A375/H19+ cells significantly increased (P < 0.001). The expression levels of MMP2 and MMP9 were significantly increased in A375/H19+ cells, as determined by qPCR and Western blotting (P < 0.001). Moreover, A375/H19+ cells had upregulated levels of Slug and p-Akt and downregulated E-cadherin (P < 0.001). The weight and volume of A375/H19+ cell xenografts in nude mice were significantly increased, but its inhibition rate was smaller (P < 0.05 and P < 0.001, respectively).
CONCLUSIONS: The results of this study showed that H19 overexpression promoted the proliferation, invasion, and growth of A375 cells. In addition, it upregulated the mRNA and protein expression levels of MMP2 and MMP9, which in turn promoted cell invasion. Furthermore, H19 appeared to enhance Akt phosphorylation, directly suppress E-cadherin, and upregulate Slug expression to promote A375 cell invasion. IJCEP
Copyright © 2018.

Entities:  

Keywords:  H19; human melanoma; invasion; proliferation

Year:  2018        PMID: 31938202      PMCID: PMC6958159     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice.

Authors:  Kazuhiko Ikeda; Philip J Mason; Monica Bessler
Journal:  Blood       Date:  2011-04-01       Impact factor: 22.113

3.  Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.

Authors:  L Yan; J Zhou; Y Gao; S Ghazal; L Lu; S Bellone; Y Yang; N Liu; X Zhao; A D Santin; H Taylor; Y Huang
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

4.  H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.

Authors:  J S Chen; Y F Wang; X Q Zhang; J M Lv; Y Li; X X Liu; T P Xu
Journal:  Neoplasma       Date:  2016       Impact factor: 2.575

5.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

6.  The imprinted H19 lncRNA antagonizes let-7 microRNAs.

Authors:  Amanda N Kallen; Xiao-Bo Zhou; Jie Xu; Chong Qiao; Jing Ma; Lei Yan; Lingeng Lu; Chaochun Liu; Jae-Sung Yi; Haifeng Zhang; Wang Min; Anton M Bennett; Richard I Gregory; Ye Ding; Yingqun Huang
Journal:  Mol Cell       Date:  2013-09-19       Impact factor: 17.970

Review 7.  Epithelial to Mesenchymal Transition in a Clinical Perspective.

Authors:  Jennifer Pasquier; Nadine Abu-Kaoud; Haya Al Thani; Arash Rafii
Journal:  J Oncol       Date:  2015-09-06       Impact factor: 4.375

8.  H19 activates Wnt signaling and promotes osteoblast differentiation by functioning as a competing endogenous RNA.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Yu-Bing Wang; Yu-Xin Sun; Liang-Liang Xu; Cheuk-Wa Wong; Kai-Ming Chan; Gang Li; Mary Miu-Yee Waye; Jin-Fang Zhang
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

9.  RNA sequencing of db/db mice liver identifies lncRNA H19 as a key regulator of gluconeogenesis and hepatic glucose output.

Authors:  Neha Goyal; Ambily Sivadas; K V Shamsudheen; Rijith Jayarajan; Ankit Verma; Sridhar Sivasubbu; Vinod Scaria; Malabika Datta
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

10.  Ultraviolet Radiation-Induced Cytogenetic Damage in White, Hispanic and Black Skin Melanocytes: A Risk for Cutaneous Melanoma.

Authors:  Amrita Dasgupta; Meena Katdare
Journal:  Cancers (Basel)       Date:  2015-08-14       Impact factor: 6.639

View more
  4 in total

1.  Transcriptional network constituted of CBP, Ku70, NOX2, and BAX prevents the cell death of necrosis, paraptosis, and apoptosis in human melanoma.

Authors:  Liang Ding; Yalei Wen; Xin Zhang; Fang Zhao; Kenao Lv; Jian-Hong Shi; Shigang Shen; Xuefeng Pan
Journal:  Cell Death Discov       Date:  2021-02-26

Review 2.  LncRNA H19: A novel oncogene in multiple cancers.

Authors:  Jun Yang; Manlong Qi; Xiang Fei; Xia Wang; Kefeng Wang
Journal:  Int J Biol Sci       Date:  2021-07-25       Impact factor: 6.580

Review 3.  Long Noncoding RNA H19: A Novel Therapeutic Target Emerging in Oncology Via Regulating Oncogenic Signaling Pathways.

Authors:  Baokang Wu; Yizhou Zhang; Yang Yu; Chongli Zhong; Qi Lang; Zhiyun Liang; Chao Lv; Feng Xu; Yu Tian
Journal:  Front Cell Dev Biol       Date:  2021-12-16

4.  A Non-Coding RNA Network Involved in KSHV Tumorigenesis.

Authors:  Julián Naipauer; Martín E García Solá; Daria Salyakina; Santas Rosario; Sion Williams; Omar Coso; Martín C Abba; Enrique A Mesri; Ezequiel Lacunza
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.